PROLEVIATE - AN OVERVIEW

Reports really should incorporate people with better pain severity (higher than fifty/100 with a 100‐stage Visible analogue scale) at baseline. People with mild‐average pain must even now be incorporated, but it would be sensible to separate the outcomes for Evaluation, guaranteeing the study is sufficiently powered to allow this subgroup Evalu